Valerio Therapeutics Société anonyme (LON:0NWK)

LON:0NWK Statistics

Total Valuation

LON:0NWK has a market cap or net worth of GBP 7.18 million. The enterprise value is 21.05 million.

Market Cap	7.18M
Enterprise Value	21.05M

Important Dates

The last earnings date was Friday, June 27, 2025.

Earnings Date	Jun 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	153.88M
Shares Outstanding	n/a
Shares Change (YoY)	+13.81%
Shares Change (QoQ)	-12.27%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	62.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.84
PB Ratio	-1.05
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.06
EV / Sales	13.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.99

Financial Position

The company has a current ratio of 0.25

Current Ratio	0.25
Quick Ratio	0.25
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.30
Interest Coverage	-52.68

Financial Efficiency

Return on equity (ROE) is -731.83% and return on invested capital (ROIC) is -60.44%.

Return on Equity (ROE)	-731.83%
Return on Assets (ROA)	-38.74%
Return on Invested Capital (ROIC)	-60.44%
Return on Capital Employed (ROCE)	4,041.66%
Revenue Per Employee	39,020
Profits Per Employee	-520,795
Employee Count	19
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

In the past 12 months, LON:0NWK has paid 311,768 in taxes.

Income Tax	311,768
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.95% in the last 52 weeks. The beta is 1.75, so LON:0NWK's price volatility has been higher than the market average.

Beta (5Y)	1.75
52-Week Price Change	-53.95%
50-Day Moving Average	0.06
200-Day Moving Average	0.41
Relative Strength Index (RSI)	37.08
Average Volume (20 Days)	3,261

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0NWK had revenue of GBP 1.48 million and -19.79 million in losses. Loss per share was -0.13.

Revenue	1.48M
Gross Profit	1.06M
Operating Income	-13.64M
Pretax Income	-19.48M
Net Income	-19.79M
EBITDA	-3.22M
EBIT	-13.64M
Loss Per Share	-0.13

Balance Sheet

The company has 974,170 in cash and 13.70 million in debt, giving a net cash position of -12.72 million.

Cash & Cash Equivalents	974,170
Total Debt	13.70M
Net Cash	-12.72M
Net Cash Per Share	n/a
Equity (Book Value)	-6.83M
Book Value Per Share	-0.05
Working Capital	-11.39M

Cash Flow

In the last 12 months, operating cash flow was -10.30 million and capital expenditures -263,803, giving a free cash flow of -10.57 million.

Operating Cash Flow	-10.30M
Capital Expenditures	-263,803
Free Cash Flow	-10.57M
FCF Per Share	n/a

Margins

Gross Margin	71.39%
Operating Margin	-919.69%
Pretax Margin	-1,313.66%
Profit Margin	n/a
EBITDA Margin	-217.29%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0NWK does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.81%
Shareholder Yield	-13.81%
Earnings Yield	-275.63%
FCF Yield	-147.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0NWK has an Altman Z-Score of -7.13 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.13
Piotroski F-Score	4